A new look at stored blood from a landmark lifestyle trial found that adding the DASH eating pattern produced broader changes in fats, amino acids, and inflammation-related markers. The paper was published November 6, 2026, but the original PREMIER intervention ran from 1998 to 2004.
What changed
Researchers analyzed 690 adults who had been randomly assigned to advice alone, intensive lifestyle counseling, or counseling plus DASH. After six months, lifestyle counseling lowered very-low-density lipoprotein cholesterol and saturated fatty acids. Adding DASH was linked to broader shifts, including higher omega-3 fatty acids and lower branched-chain amino acids, lactate, and GlycA, an inflammation-related marker. Changes in body mass index tracked with several blood patterns, suggesting weight loss drove much of the result.
How strong is the evidence?
This is a secondary analysis of a randomized human trial, using samples from 690 participants. Randomization is a strength, and the authors reported no conflicts of interest. However, the new analysis was not the trial’s original primary outcome.
What remains uncertain
The measured metabolites are surrogate markers—not proof of fewer heart attacks, diabetes cases, or deaths. The intervention also combined diet, sodium reduction, exercise, alcohol moderation, and weight control, so the separate contribution of DASH cannot be measured precisely.
Why it matters
The findings support a familiar pattern rich in vegetables, fruit, whole grains, beans, nuts, and low-fat dairy rather than a supplement. See our Pantry & Kitchen guide and our report on Mediterranean eating, fasting, and inflammation. People with kidney disease or medicines affecting potassium should personalize major diet changes with a clinician.
Illustrative stock photo by Randy Fath on Unsplash. It does not show trial participants, study meals, blood samples, or results.
Sources
Original analysis in The Journal of Nutrition, published November 6, 2026; PREMIER trial record.
